Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
71.00    1.00 (1.43%)
Bid:
70.00
Ask:
72.00
Spread: 2.00 (2.857%)
Market Cap: £323.13m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Avacta Group News

Avacta shares fall as interim revenues slide
9 Apr 2019

Avacta shares fall as interim revenues slide

(Sharecast News) - Biotherapeutics and research reagents developer Avacta Group reported a fall in half-year revenues to £1.0m on Tuesday, from £1.5m ...

Avacta Shares Fall On Widened Interim Loss, Lower Revenue
9 Apr 2019

Avacta Shares Fall On Widened Interim Loss, Lower Revenue

LONDON (Alliance News) - Avacta Group PLC on Tuesday reported a widened first half loss mainly due to lower income contribution from life sciences uni...

Avacta Hires IP Group Unit Boss Sam Williams As Non-Executive Director
28 Jan 2019

Avacta Hires IP Group Unit Boss Sam Williams As Non-Executive Director

LONDON (Alliance News) - Avacta Group PLC on Monday said it has appointed Sam Williams as a non-executive director with immediate effect.The biotechno...

Avacta Group makes solid development progress
21 Jan 2019

Avacta Group makes solid development progress

(Sharecast News) - Biotherapeutics developer Avacta Group updated the market on its trading on Monday, as investors gathered for its annual general me...

IP Group Builds Over 17% Holding In Biotechnology Firm Avacta (ALLISS)
3 Jan 2019

IP Group Builds Over 17% Holding In Biotechnology Firm Avacta (ALLISS)

LONDON (Alliance News) - Avacta Group PLC on Thursday said IP Group PLC now holds 17.2% stake in the biotechnology company following a transaction on ...

Avacta Group Appoints Roche's Jose Saro As Chief Medical Officer
12 Dec 2018

Avacta Group Appoints Roche's Jose Saro As Chief Medical Officer

LONDON (Alliance News) - Reagents developer Avacta Group PLC on Wednesday appointed Jose Saro as chief medical officer to lead the firm's therapeutic ...

Avacta Group picks up Jose Saro as chief medical officer
12 Dec 2018

Avacta Group picks up Jose Saro as chief medical officer

(Sharecast News) - Biotherapeutic development company Avacta Group announced on Wednesday that Dr Jose Saro has been appointed as its chief medical of...

IP Group Investee Teams With LG Chem To Develop Affimer Drug Candidate
10 Dec 2018

IP Group Investee Teams With LG Chem To Develop Affimer Drug Candidate

LONDON (Alliance News) - IP Group PLC on Monday said its portfolio company Avacta Group PLC signed a development & license deal with LG Chem Life Scie...